The effects of NF-κB and c-Jun/AP-1 on the expression of prothrombotic and proinflammatory molecules induced by anti-β2GPI in mouse

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Xia, Longfei ^a   Xie, Hongxiang ^a   Yu, Yinjing ^a   Zhou, Hong ^a,b   Wang, Ting ^a   Yan, Jinchuan ^b  

^a JIANGSU UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CURCUMIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN C JUN; PYRROLIDINE DITHIOCARBAMATE; THROMBOPLASTIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ANTIBODY; BETA2 GLYCOPROTEIN 1; PROLINE; PROLINEDITHIOCARBAMATE; THIOCARBAMIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; E SELECTIN GENE; GENE EXPRESSION REGULATION; ICAM 1 GENE; IL 1BETA GENE; IL 6 GENE; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TF GENE; THROMBOSIS; TNF ALPHA GENE; UPREGULATION; VCAM 1 GENE; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIBODIES; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CURCUMIN; E-SELECTIN; IMMUNOGLOBULIN G; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES, PERITONEAL; MALE; MICE, INBRED BALB C; NF-KAPPA B; PHOSPHORYLATION; PROLINE; REAL-TIME POLYMERASE CHAIN REACTION; THIOCARBAMATES; THROMBOPLASTIN; THROMBOSIS; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84958787321     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147958     Document Type: Article

References (49)

1. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010; 376(9751):1498-1509. doi: 10.1016/S0140-6736(10)60709-X PMID: 20822807
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4(2): 295-306. PMID: 16420554
3. Mehdi AA, Uthman I, Khamashta M. Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future. Eur J Clin Invest. 2010; 40(5): 451-464. doi: 10.1111/j.1365-2362. 2010.02281.x PMID: 20345380
4. Willis R, Pierangeli SS. Anti-β2-glycoprotein I antibodies. Ann N Y Acad Sci. 2013; 1285: 44-58. doi: 10.1111/nyas.12080 PMID: 23692565
5. Allen KL, Fonseca FV, Betapudi V, Willard B, Zhang J, McCrae KR. A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. Blood. 2012; 119(3): 884-893. doi: 10.1182/blood-2011-03-344671 PMID: 22106343
6. Arad A, Proulle V, Furie RA, Furie BC, Furie B. β2 glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood. 2011; 117(12): 3453-3459. doi: 10.1182/blood-2010-08-300715 PMID: 21245481
7. Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR. High affinity binding of beta2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem. 2000; 275(20):15541-15548. PMID: 10809787
8. Raschi E, Borghi MO, Grossi C, Broggini V, Pierangeli S, Meroni PL. Toll-like receptors: another player in the pathogenesis of the antiphospholipid syndrome. Lupus. 2008; 17(10): 937-942. doi: 10.1177/ 0961203308095140 PMID: 18827059
9. Chaturvedi S, McCrae KR. Recent advances in the antiphospholipid antibody syndrome. Curr Opin Hematol. 2014; 21(5): 371-379. doi: 10.1097/MOH.0000000000000067 PMID: 25023470
10. Clemens N, Frauenknecht K, Katzav A, Sommer C, von Landenberg P. In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes. Ann N Y Acad Sci. 2009; 1173: 805-813. doi: 10.1111/j.1749-6632.2009.04632.x PMID: 19758232
11. Forastiero RR, Martinuzzo ME, de Larranaga GF. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies. Lupus. 2005; 14(2): 129-136. PMID: 15751817
12. Pierangeli SS, Colden-Stanfield M, Liu X, Barker JH, Anderson GL, Harris EN. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation. 1999; 99(15):1997-2002. PMID: 10209004
13. Pierangeli SS, Liu XW, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost. 1995; 74(5): 1361-1367. PMID: 8607123
14. Jankowski M, Vreys I, Wittevrongel C, Boon D, Vermylen J, Hoylaerts MF, et al. Thrombogenicity of beta2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood. 2003; 101(1): 157-162. PMID: 12393462
15. Vega-Ostertag ME, Ferrara DE, Romay-Penabad Z, Liu X, Taylor WR, Colden-Stanfield M, et al. Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation. J Thromb Haemos. 2007; 5(9): 1828-1834.
16. Vega-Ostertag M, Casper K, Swerlick R, Ferrara D, Harris EN, Pierangeli SS. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum. 2005; 52(5): 1545-1554. PMID: 15880836
17. Xia L, Zhou H, Hu L, Xie H, Wang T, Xu Y, et al. Both NF-κappaB and c-Jun/AP-1 involved in anti-β2GPI/β2GPI-induced tissue factor expression in monocytes. Thromb Haemost. 2013; 109(4): 643-651. doi: 10.1160/TH12-09-0655 PMID: 23467542
18. Wang S, Liu Z, Wang L, Zhang X. NF-κappa B signalling pathway, inflammation and colorectal cancer. Cell Mol Immunol. 2009; 6(5): 327-334. doi: 10.1038/cmi.2009.43 PMID: 19887045
19. Guo D, Zhou H, Wu Y, Zhou F, Xu G, Wen H, et al. Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620. Tumor Biol. 2011; 32(5): 921-930.
20. Kappelmann M, Bosserhoff A, Kuphal S. AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma. Eur J Cell Biol. 2014; 93(1-2): 76-81. doi: 10.1016/j.ejcb.2013.10.003 PMID: 24315690
21. Vaiopoulos AG, Papachroni KK, Papavassiliou AG. Colon carcinogenesis: Learning from NF-κB and AP-1. Int J Biochem Cell Biol. 2010; 42(7): 1061-1065. doi: 10.1016/j.biocel.2010.03.018 PMID: 20348011
22. Xie H, Sheng L, Zhou H, Yan J. The role of TLR4 in pathophysiology of antiphospholipid syndromeassociated thrombosis and pregnancy morbidity. Br J Haematol. 2014; 164(2): 165-176. doi: 10.1111/ bjh.12587 PMID: 24180619
23. Borghi MO, Raschi E, Grossi C, Chighizola CB, Meroni PL. Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells. Lupus. 2014; 23(12): 1302-1304. doi: 10.1177/0961203314536479 PMID: 25228733
24. Boles J, Mackman N. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Lupus. 2010; 19(4): 370-378. doi: 10.1177/0961203309360810 PMID: 20353972
25. Zhang J, McCrae KR. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2glycoprotein I antibodies. Blood. 2005; 105(5): 1964-1969. PMID: 15471954
26. Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C, et al. Anti-β2Glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum. 2007; 56(8): 2687-2697. PMID: 17665396
27. Efthymiou M, Lawrie AS, Mackie I, Arachchillage D, Lane PJ, Machin S, et al. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome. Thromb Res. 2015; 135(6):1191-1197. doi: 10.1016/j.thromres.2015.03.030 PMID: 25895847
28. Ko WC, Chen BC, Hsu MJ, Tsai CT, Hong CY, Lin CH. Thrombin induced connective tissue growth factor expression in rat vascular smooth muscle cells via the PAR-1/JNK/AP-1 pathway. Acta Pharmacol Sin. 2012; 33(1): 49-56. doi: 10.1038/aps.2011.178 PMID: 22212430
29. Dunoyer-Geindre S, de Moerloose P, Galve-de Rochemonteix B, Reber G, Kruithof EK. NF-κB is an essential intermediate in the activation of endothelial cells by anti-β2glycoprotein I antibodies. Thromb Haemost. 2002; 88(5): 851-857. PMID: 12428105
30. Bohgaki M, Atsumi T, Yamashita Y, Yasuda S, Sakai Y, Furusaki A, et al. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-β2glycoprotein I antibodies. Int Immunol. 2004; 16(11): 1633-1641. PMID: 15466912
31. Zhang X, Wu M, Jiang H, Hao J, Zhang Q, Zhu Q, et al. Angiotensin II upregulates endothelial lipase expression via the NF-κappa B and MAPK signaling pathways. PLoS One. 2014; 9(9): e107634. doi: 10.1371/journal.pone.0107634 PMID: 25250890
32. Seol DW, Chen Q, Zarnegar R. Transcriptional activation of the hepatocyte growth factor receptor (cmet) gene by its ligand (hepatocyte growth factor) is mediated through AP-1. Oncogene. 2000; 19(9): 1132-1137. PMID: 10713700
33. Meng Z, Yan C, Deng Q, Gao DF, Niu XL. Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways. Acta Pharmacol Sin. 2013; 34(7): 901-911. doi: 10.1038/aps.2013.24 PMID: 23645013
34. Bierhaus A, Zhang Y, Quehenberger P, Luther T, Haase M, Müller M, et al. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-κappa B. Thromb Haemost. 1997; 77(4): 772-782. PMID: 9134658
35. Seshan SV, Franzke CW, Redecha P, Monestier M, Mackman N, Girardi G. Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. Blood. 2009; 114 (8): 1675-1683. doi: 10.1182/blood-2009-01-199117 PMID: 19535796
36. Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis. 2006; 36(2): 104-107.
37. López-Pedrera C, Buendía P, Cuadrado MJ, Siendones E, Aguirre MA, Barbarroja N, et al. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-κB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. Arthritis Rheum. 2006; 54(1): 301-311.
38. Mackman N. Regulation of the tissue factor gene. FASEB J. 1995; 9(10): 883-889.
39. Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, et al. Euro-Phospholipid Project, Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015; 74(6): 1011-1018. PMID: 24464962
40. Colasanti T, Alessandri C, Capozzi A, Sorice M, Delunardo F, Longo A, et al. Autoantibodies specific to a peptide of beta2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. Blood. 2012; 120(16): 3360-3370. doi: 10.1182/blood-2011-09-378851 PMID: 22932793
41. Williams FM, Parmar K, Hughes GR, Hunt BJ. Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost. 2000; 84(5):742-746. PMID: 11127848
42. Raschi E, Testoni C, Bosisio D, Borghi MO, Koike T, Mantovani A, et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood. 2003; 101(9): 3495-3500. PMID: 12531807
43. Zhou H, Sheng L, Wang H, Xie H, Mu Y, Wang T, et al. Antib2GPI/b2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways. Thromb Res. 2013; 132(6): 742-749. PMID: 24157085
44. Zhou H, Ling S, Yu Y, Wang T, Hu H. Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes. Cell Res. 2007; 17(8): 737-739. PMID: 17438552
45. Erkan D, Willis R, Murthy VL, Basra G, Vega J, Ruiz-Limón P, et al. A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients. Ann Rheum Dis. 2014; 73(6): 1176-1180. doi: 10.1136/annrheumdis-2013-203622 PMID: 23933625
46. Xie H, Zhou H, Wang H, Chen D, Xia L, Wang T, et al. Anti-beta(2)GPI/beta(2)GPI induced TF and TNF-alpha expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways. Mol Immunol. 2013; 53(3): 246-254. doi: 10.1016/j.molimm.2012.08.012 PMID: 22964479
47. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, Uwagawa T, et al. NF-κB and AP-1 connection: mechanism of NF-κB-dependent regulation of AP-1 activity. Mol Cell Biol. 2004; 24(17): 7806-7819. PMID: 15314185
48. Meroni PL, Raschi E, Grossi C, Pregnolato F, Trespidi L, Acaia B, et al. Obstetric and vascular APS: same autoantibodies but different diseases? Lupus. 2012; 21(7): 708-710. doi: 10.1177/ 0961203312438116 PMID: 22635208
49. Chabicovsky M, Prieschl-Grassauer E, Seipelt J, Muster T, Szolar OH, Hebar A, et al. Pre-clinical safety evaluation of pyrrolidine dithiocarbamate. Basic Clin Pharmacol Toxicol. 2010; 107(3): 758-767. doi: 10.1111/j.1742-7843.2010.00573.x PMID: 20406205